Cancer stem cells (CSCs) have been identified in a growing number of malignancies and are functionally defined by their ability to undergo self-renewal and produce differentiated progeny 1 . These properties allow CSCs to recapitulate the original tumor when injected into immunocompromised mice. CSCs within an epithelial malignancy were first described in breast cancer and found to display specific cell surface antigen expression (CD44
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. These properties allow CSCs to recapitulate the original tumor when injected into immunocompromised mice. CSCs within an epithelial malignancy were first described in breast cancer and found to display specific cell surface antigen expression (CD44 + CD24 low/-) 2 . Since then, CSCs have been identified in an increasing number of other human malignancies using CD44 and CD24 as well as a number of other surface antigens. Physiologic properties, including aldehyde dehydrogenase (ALDH) activity, have also been used to isolate CSCs from malignant tissues [3] [4] [5] .
Recently, we and others identified CSCs from pancreatic adenocarcinoma based on ALDH activity and the expression of the cell surface antigens CD44 and CD24, and CD133 [6] [7] [8] . These highly tumorigenic populations may or may not be overlapping and display other functions. We found that ALDH + and CD44 + CD24 + pancreatic CSCs are similarly tumorigenic, but ALDH + cells are relatively more invasive 8 . In this protocol we describe a method to isolate viable pancreatic CSCs from low-passage human xenografts 9 . Xenografted tumors are harvested from mice and made into a single-cell suspension. Tissue debris and dead cells are separated from live cells and then stained using antibodies against CD44 and CD24 and using the ALDEFLUOR reagent, a fluorescent substrate of ALDH 10 . CSCs are then isolated by fluorescence activated cell sorting. Isolated CSCs can then be used for analytical or functional assays requiring viable cells.
Video Link
The video component of this article can be found at http://www.jove.com/video/2169/ 3. To further separate viable cells from dead cells and tissue debris, the tumor cell suspension is separated by density centrifugation using Ficoll-Paque Plus. An underlayment of Ficoll-Paque Plus is created by pipeting 15 mL of Ficoll-Paque Plus slowly below the cell suspension being careful not to mix the two layers. 4. The cell suspension and Ficoll layers are is centrifuged at 500x g for 30 minutes with the brakes turned off. 5. Cells at the interface of the Ficoll-Paque Plus and cell dissociation buffer are collected and transferred to a fresh 50-mL conical tube. 6. Fresh DMEM supplemented with 10% FCS is added to the cell suspension to dilute it 1:3 (e.g. 20 mL fresh media added to 10 mL of cell suspension). 7. The cells are collected by centrifugation at 450x g for 10 minutes, the media decanted, and the cell pellet is resuspended in 1 mL of ALDEFLUOR buffer. 8. Ten microliters of the cell suspension is diluted with 10 μL trypan blue and viable cells are counted using a hemocytometer. If a large number of dead cells or tissue debris are noted during this step, then cell separation by density centrifugation can be repeated (steps 3.3 -3.7). 2. Dilute the cell suspension in 2 mL of ALDEFLUOR buffer to a final concentration of 5-10 million cells/mL and keep on ice. Add 100 μL of the cell suspension to tubes #1, 2, 3, and 4 and keep them on ice. Add 1 μL DEAB to tube #6 and keep on ice. Add ALDEFLUOR reagent to the remaining cell suspension diluted 1000-fold (e.g. add 1.6 μL ALDEFLUOR reagent to 1.6 mL cell suspension), mix well, and place on ice.
Stain Cells for Fluorescence Activated Cell Sorting
Transfer 100 μL of this mixture to tubes #5 and 6, and the remaining mixture (1.4 mL) to tube #7. Incubate all of the tubes in a 37°C water bath for 40 minutes. Mix the cell suspension every 10 minutes in order to prevent the cells from settling to the bottom of the tubes. fresh DMEM supplemented with 10% FCS. 9. Count the number of sorted cells using a hemocytometer as described in step 3.8.
Isolate Cancer Stem Cells by Fluorescence Activated Cell Sorting

Representative Results
This protocol will lead to the isolation of ALDH + and CD44 + CD24 + pancreatic CSCs. The percentage of mouse-derived cells is variable, but we have found that most human pancreatic cancer xenografts contain 20-60% mouse-derived cells using the mouse CD31, mouse lineage cocktail, and mouse H-2Kd biotin-conjugated antibodies ( Figure 1A ). Likewise the frequency of each CSC population from different xenografts is variable, but generally we have found that 1-4% of the total cell population is ALDH + ( Figure 1B ) and 0.2-5% is CD44 + CD24 + ( Figure 1C ).
We routinely manually count sorted cells using a hemocytometer since the FACSAria machine counts are often inaccurate due to non-cellular particles detected by the FACSAria. 
Discussion
This protocol describes the isolation of pancreatic CSCs from human xenografts. Several key steps in this procedure will enhance the yield of viable CSCs. The recovery of a pure population of pancreatic CSCs is dependent on the purity of viable cells present in the cell suspension before sorting on the FACSAria. Taking care to use xenografts that are less than 1-cm in greatest diameter helps to reduce the amount of necrotic tissue in the center of the tumor. Additionally, depleting the cell suspension of tissue debris and dead cells during Ficoll-Paque gradient centrifugation is critical and can be repeated if a large number of tissue debris or non-viable cells are detected when the cells are counted on the hemocytometer.
The staining protocol described here utilizes the ALDEFLUOR reagent system to detect ALDH activity as well as fluorophore-conjugated antibodies to detect specific cell surface antigens. ALDEFLUOR staining is performed at 37°C and, therefore, needs to be completed before antibody staining (on ice) to prevent the potential for antibody capping, which can happen at 37°C. Since cells can efflux the ALDEFLUOR reagent, it is important to maintain the cells in ALDEFLUOR buffer at 4°C after ALDEFLUOR staining has been completed. The ALDEFLUOR buffer contains a drug efflux inhibitor that helps maintain intracellular levels of ALDEFLUOR.
Since this method isolates viable pancreatic CSCs they can be applied in a number of experiments that measure the physiological function of these cells. We have used these cells for tumor-initiation assays utilizing immunocompromised mice and in vitro cell migration/invasion assays. Furthermore, RNA, DNA, and protein can be collected from these cells for analytical studies comparing CSC and non-CSC populations.
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